Evaluating the Performance of Classical PK Models, 2nd‐Gen MPBPK Models, and MPBPK Models with TMDD in Predicting Therapeutic Monoclonal Antibody PK in Human

Document Type

Conference Proceeding

Publication Date

3-2018

DOI

10.1002/cpt.993


Share

COinS